InvestorsHub Logo
Post# of 175031
Next 10
Followers 23
Posts 4383
Boards Moderated 0
Alias Born 07/15/2012

Re: None

Thursday, 01/18/2024 10:28:22 AM

Thursday, January 18, 2024 10:28:22 AM

Post# of 175031
Radiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designation
Published: Dec 20, 2023

Richland WA, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to announce that the Food and Drug Administration has granted RadioGel Precision Radionuclide Therapy the designation as a Breakthrough Device pursuant to the FDA’s Breakthrough Devices Program.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDGL News